At a Glance
Rheumatoid Arthritis, Crohn's Disease
An anti-TNF biologic which has been approved for the treatment of Crohn's disease in the United States and for the treatment of rheumatoid arthritis in the United States and in the European Union. Cimzia blocks the action of tumor necrosis factor-alpha, a protein that plays a role in causing inflammation in rheumatoid arthritis.
Applications In Development: